Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions

Clinical trial NCT03073109 · COMPLETED

Trial details

NCT number: NCT03073109
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Arthritis, Rheumatoid

Start date: 2017-03-15
Primary completion: 2019-09-16
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.